English
Safety, tolerability and pharmacodynamics of a novel immunomodulator, MIS416, in patients with chronic progressive multiple sclerosis
Overview of attention for article published in Multiple Sclerosis Journal – Experimental, Translational and Clinical, May 2015
Altmetric Badge
About this Attention Score
-
Good Attention Score compared to outputs of the same age (65th percentile)
-
Good Attention Score compared to outputs of the same age and source (66th percentile)
Readers on
- mendeley
- 20 Mendeley